IMMIX BIOPHARMA, INC. (IMMX) Free cash flow 2021–2025
IMMIX BIOPHARMA, INC. (IMMX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$24.7MFY2025 · since FY2021: -$1.6M → -$24.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.7M | -56.4% |
| FY2024 | -$15.8M | -38.1% |
| FY2023 | -$11.4M | — |
| FY2021 | -$1.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice